Publicaciones en colaboración con investigadores/as de Instituto de Salud Global de Barcelona (19)

2023

  1. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  2. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  2. Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3009-3015

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Uptake of ozenoxacin and other quinolones in gram-positive bacteria

    International Journal of Molecular Sciences, Vol. 22, Núm. 24

2020

  1. Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 3

2019

  1. Collaborative intelligence and gamification for on-line malaria species differentiation

    Malaria Journal, Vol. 18, Núm. 1

  2. Microbiological profile of ozenoxacin

    Future Microbiology, Vol. 14, Núm. 9, pp. 773-787

  3. Mutant prevention concentration of ozenoxacin for quinolone-susceptible or - resistant Staphylococcus aureus and Staphylococcus epidermidis

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates

    Future Microbiology, Vol. 13, Núm. 6s, pp. 3-19

  2. Factors influencing access of pregnant women and their infants to their local healthcare system: A prospective, multi-centre, observational study

    BMC Pregnancy and Childbirth, Vol. 18, Núm. 1

2016

  1. Escherichia coli: An old friend with new tidings

    FEMS Microbiology Reviews, Vol. 40, Núm. 4, pp. 437-463

2015

  1. Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 4, pp. 1047-1050

  2. In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 1, pp. 57-61

2014

  1. Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values

    Diagnostic Microbiology and Infectious Disease, Vol. 78, Núm. 3, pp. 263-267

2013

  1. In vitro activity of ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 12, pp. 6389-6392

  2. Red blood cells derived from peripheral blood and bone marrow CD34+ human haematopoietic stem cells are permissive to Plasmodium parasites infection

    Memorias do Instituto Oswaldo Cruz, Vol. 108, Núm. 6, pp. 801-803

  3. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183